Crossmark

Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma

Crossref DOI link: https://doi.org/10.1007/s12072-022-10419-3

Published Online: 2022-09-20

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Linghao https://orcid.org/0000-0001-7467-0566
Wang, Yuyouye

Tian, Tao

Rao, Xinjie

Dong, Wei

Zhang, Jinmin

Yang, Yuan

Tao, Qifei

Peng, Fang

Shen, Chenhang

Wang, Songbo

Liu, Hui

Zeng, Xi

Zhou, Weiping
Funding

Funding for this research was provided by:

Shanghai Rising-Star Program (20QA1412000)

National Natural Science Foundation of China (82072759, 31900479)
License Information

Text and Data Mining valid from 2022-09-20

Version of Record valid from 2022-09-20
More Information

Article History

Received: 23 May 2022

Accepted: 24 August 2022

First Online: 20 September 2022

Declarations

:

: The authors declare that they have no competing interests.

: The protocols used in this study were approved by the Ethical Review Committees of Eastern Hepatobiliary Surgery Hospital, and written informed consent was provided from all the patients.

: All subjects have written informed consent.

Document is current

Any future updates will be listed below